{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:19:25Z","timestamp":1792556365454,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5-6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.2119\/2007-00101.yu","type":"journal-article","created":{"date-parts":[[2008,5,16]],"date-time":"2008-05-16T11:47:43Z","timestamp":1210938463000},"page":"264-275","source":"Crossref","is-referenced-by-count":79,"title":["Differential Expression of Receptor Tyrosine Kinases (RTKs) and IGF-I Pathway Activation in Human Uterine Leiomyomas"],"prefix":"10.1186","volume":"14","author":[{"given":"Linda","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Saile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol D.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantelle","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Robboy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,25]]},"reference":[{"key":"1405264_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ogc.2005.12.004","volume":"33","author":"M Payson","year":"2006","unstructured":"Payson M, Leppert P, Segars J. (2006) Epidemiology of myomas. Obstet. Gynecol. Clin. North Am. 33:1\u201311.","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"1405264_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1089\/jwh.2005.14.692","volume":"14","author":"J Mauskopf","year":"2005","unstructured":"Mauskopf J, Flynn M, Thieda P, Spalding J, Duchane J. (2005) The economic impact of uterine fibroids in the United States: a summary of published estimates. J. Womens Health. (Larchmt) 14:692\u2013703.","journal-title":"J. Womens Health. (Larchmt)"},{"key":"1405264_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","volume":"104","author":"EE Wallach","year":"2004","unstructured":"Wallach EE, Vlahos NF. (2004) Uterine myomas: an overview of development, clinical features, and management. Obstet. Gynecol. 104:393\u2013406.","journal-title":"Obstet. Gynecol."},{"key":"1405264_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.critrevonc.2003.08.004","volume":"50","author":"A Bennasroune","year":"2004","unstructured":"Bennasroune A, Gardin A, Aunis D, Cremel G, Hubert P. (2004) Tyrosine kinase receptors as attractive targets of cancer therapy. Crit. Rev. Oncol. Hematol. 50:23\u201338.","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"Suppl 5","key":"1405264_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1289\/ehp.00108s5795","volume":"108","author":"D Dixon","year":"2000","unstructured":"Dixon D, He H, Haseman JK. (2000) Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ. Health Perspect. 108Suppl 5:795\u2013802.","journal-title":"Environ. Health Perspect."},{"key":"1405264_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ogc.2005.12.011","volume":"33","author":"PK Brahma","year":"2006","unstructured":"Brahma PK, Martel KM, Christman GM. (2006) Future directions in myoma research. Obstet. Gynecol. Clin. North Am. 33:199\u2013224, xiii.","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"1405264_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1126\/science.1112063","volume":"308","author":"CL Walker","year":"2005","unstructured":"Walker CL, Stewart EA. (2005) Uterine fibroids: the elephant in the room. Science. 308:1589\u201392.","journal-title":"Science"},{"key":"1405264_CR8","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1289\/ehp.5787","volume":"111","author":"GP Flake","year":"2003","unstructured":"Flake GP, Andersen J, Dixon D. (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environ. Health Perspect. 111:1037\u201354.","journal-title":"Environ. Health Perspect."},{"key":"1405264_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1677\/joe.0.1720083","volume":"172","author":"KD Burroughs","year":"2002","unstructured":"Burroughs KD, Howe SR, Okubo Y, Fuchs-Young R, LeRoith D, Walker CL. (2002) Dysregulation of IGF-I signaling in uterine leiomyoma. J. Endocrinol. 172:83\u201393.","journal-title":"J. Endocrinol."},{"key":"1405264_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/modpathol.3800283","volume":"18","author":"J Wei","year":"2005","unstructured":"Wei J, Chiriboga L, Mizuguchi M, Yee H, Mittal K. (2005) Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata. Mod. Pathol. 18:179\u201388.","journal-title":"Mod. Pathol."},{"key":"1405264_CR11","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1093\/oxfordjournals.humrep.a137937","volume":"8","author":"LC Giudice","year":"1993","unstructured":"Giudice LC et al. (1993) Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum. Reprod. 8:1796\u2013806.","journal-title":"Hum. Reprod."},{"key":"1405264_CR12","first-page":"311","volume":"73","author":"R Rubin","year":"1995","unstructured":"Rubin R, Baserga R. (1995) Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab. Invest. 73:311\u201331.","journal-title":"Lab. Invest."},{"key":"1405264_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/gcc.10157","volume":"36","author":"H Werner","year":"2003","unstructured":"Werner H, Roberts CT Jr. (2003) The IGFI receptor gene: a molecular target for disrupted transcription factors. Genes Chromosomes Cancer 36:113\u2013120.","journal-title":"Genes Chromosomes Cancer"},{"key":"1405264_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/B:HIJO.0000032356.98363.a2","volume":"35","author":"L Mauro","year":"2004","unstructured":"Mauro L, Surmacz E. (2004) IGF-I receptor, cell-cell adhesion, tumor development and progression. J. Mol. Histol. 35:247\u201353.","journal-title":"J. Mol. Histol."},{"key":"1405264_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/molehr\/gah174","volume":"11","author":"CD Swartz","year":"2005","unstructured":"Swartz CD, Afshari CA, Yu L, Hall KE, Dixon D. (2005) Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol. Hum. Reprod. 11:441\u201350.","journal-title":"Mol. Hum. Reprod."},{"key":"1405264_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2307\/2530051","volume":"38","author":"WJ Conover","year":"1982","unstructured":"Conover WJ, Iman RL. (1982) Analysis of covariance using the rank transformation. Biometrics. 38:715\u201324.","journal-title":"Biometrics"},{"key":"1405264_CR17","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/humrep\/deh698","volume":"20","author":"AA Arslan","year":"2005","unstructured":"Arslan AA et al. (2005) Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum. Reprod. 20:852\u201363.","journal-title":"Hum. Reprod."},{"key":"1405264_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00428-001-0568-7","volume":"441","author":"D Dixon","year":"2002","unstructured":"Dixon D et al. (2002) Cell proliferation and apoptosis in human uterine leiomyomas and myometria. Virchows Arch. 441:53\u201362.","journal-title":"Virchows Arch."},{"key":"1405264_CR19","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/humrep\/del035","volume":"21","author":"J Wang","year":"2006","unstructured":"Wang J et al. (2006) A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells. Hum. Reprod. 21:1869\u201377.","journal-title":"Hum. Reprod."},{"key":"1405264_CR20","first-page":"1179","volume":"78","author":"ML Harrison-Woolrych","year":"1994","unstructured":"Harrison-Woolrych ML, Charnock-Jones DS, Smith SK. (1994) Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction. J. Clin. Endocrinol. Metab. 78:1179\u201384.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1405264_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1055\/s-2007-1018888","volume":"10","author":"MS Rein","year":"1992","unstructured":"Rein MS, Nowak RA. (1992) Biology of uterine myomas and myometrium in vitro. Semin. Reprod. Endocrinol. 10:310\u20139.","journal-title":"Semin. Reprod. Endocrinol."},{"key":"1405264_CR22","first-page":"2192","volume":"83","author":"Y Shimomura","year":"1998","unstructured":"Shimomura Y, Matsuo H, Samoto T, Maruo T. (1998) Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J. Clin. Endocrinol. Metab. 83:2192\u20138.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1405264_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/humupd\/2.4.295","volume":"2","author":"EA Stewart","year":"1996","unstructured":"Stewart EA, Nowak RA. (1996) Leiomyomarelated bleeding: a classic hypothesis updated for the molecular era. Hum. Reprod. Update. 2:295\u2013306.","journal-title":"Hum. Reprod. Update."},{"key":"1405264_CR24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1095\/biolreprod53.3.636","volume":"53","author":"RS Mangrulkar","year":"1995","unstructured":"Mangrulkar RS, Ono M, Ishikawa M, Takashima S, Klagsbrun M, Nowak RA. (1995) Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biol. Reprod. 53:636\u201346.","journal-title":"Biol. Reprod."},{"key":"1405264_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biochi.2005.07.014","volume":"88","author":"M Wolanska","year":"2006","unstructured":"Wolanska M, Bankowski E. (2006) Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumor growth. Biochimie. 88:141\u20136.","journal-title":"Biochimie"},{"key":"1405264_CR26","first-page":"30","volume":"60","author":"YM Fayed","year":"1989","unstructured":"Fayed YM, Tsibris JC, Langenberg PW, Robertson AL Jr. (1989) Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. Lab. Invest. 60:30\u20137.","journal-title":"Lab. Invest."},{"key":"1405264_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4161\/cbt.5.1.2234","volume":"5","author":"M Liang","year":"2006","unstructured":"Liang M, Wang H, Zhang Y, Lu S, Wang Z. (2006) Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata. Cancer Biol. Ther. 5:28\u201333.","journal-title":"Cancer Biol. Ther."},{"key":"1405264_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejogrb.2006.01.034","volume":"130","author":"M Wolanska","year":"2007","unstructured":"Wolanska M, Bankowski E. (2007) Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumor growth. Eur. J. Obstet. Gynecol. Reprod. Biol. 130:238\u201344.","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1405264_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/mrd.1080270203","volume":"27","author":"KD Boehm","year":"1990","unstructured":"Boehm KD, Daimon M, Gorodeski IG, Sheean LA, Utian WH, Ilan J. (1990) Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol. Reprod. Dev. 27:93\u2013101.","journal-title":"Mol. Reprod. Dev."},{"key":"1405264_CR30","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/j.1460-2075.1988.tb02954.x","volume":"7","author":"JW Hoppener","year":"1988","unstructured":"Hoppener JW et al. (1988) Expression of insulinlike growth factor-I and -II genes in human smooth muscle tumours. Embo. J. 7:1379\u201385.","journal-title":"Embo. J."},{"key":"1405264_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00404-003-0534-5","volume":"270","author":"GK Toscani","year":"2004","unstructured":"Toscani GK et al. (2004) Gene expression and tyrosine kinase activity of insulin receptor in uterine leiomyoma and matched myometrium. Arch. Gynecol. Obstet. 270:170\u20133.","journal-title":"Arch. Gynecol. Obstet."},{"key":"1405264_CR32","first-page":"658","volume":"74","author":"P Tommola","year":"1989","unstructured":"Tommola P, Pekonen F, Rutanen EM. (1989) Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata. Obstet. Gynecol. 74:658\u201362.","journal-title":"Obstet. Gynecol."},{"key":"1405264_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/0002-9378(92)91831-T","volume":"166","author":"Y Chandrasekhar","year":"1992","unstructured":"Chandrasekhar Y, Heiner J, Osuamkpe C, Nagamani M. (1992) Insulin-like growth factor I and II binding in human myometrium and leiomyomas. Am. J. Obstet. Gynecol. 166:64\u20139.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1405264_CR34","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/bjc.1997.278","volume":"75","author":"LT Ven Van der","year":"1997","unstructured":"Van der Ven LT et al. (1997) Expression of insulinlike growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues. Br. J. Cancer. 75:1631\u201340.","journal-title":"Br. J. Cancer."},{"key":"1405264_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","volume":"103","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger J. (2000) Cell signaling by receptor tyrosine kinases. Cell. 103:211\u201325.","journal-title":"Cell"},{"key":"1405264_CR36","first-page":"269","volume-title":"Hormones and Growth Factors in Development and Neoplasia","author":"R Baserga","year":"1998","unstructured":"Baserga R. (1998) The IGF-I Receptor in Normal and Abnormal Growth. In: Hormones and Growth Factors in Development and Neoplasia. Dickson RB, Salomon DS (ed.) Wiley-Liss Inc, Wilmington, DE, pp. 269\u201387."},{"key":"1405264_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ijc.2910590323","volume":"59","author":"LT Ven van der","year":"1994","unstructured":"van der Ven LT et al. (1994) Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I. Int. J. Cancer. 59:427\u201334.","journal-title":"Int. J. Cancer."},{"key":"1405264_CR38","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/molehr\/6.10.915","volume":"6","author":"K Englund","year":"2000","unstructured":"Englund K, Lindblom B, Carlstrom K, Gustavsson I, Sjoblom P, Blanck A. (2000) Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions. Mol. Hum. Reprod. 6:915\u201320.","journal-title":"Mol. Hum. Reprod."},{"key":"1405264_CR39","first-page":"359","volume":"15","author":"M Wolanska","year":"2004","unstructured":"Wolanska M, Bankowski E. (2004) An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of tumour growth. Eur. Cytokine Netw. 15:359\u201363.","journal-title":"Eur. Cytokine Netw."},{"key":"1405264_CR40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1055\/s-2004-814166","volume":"35","author":"R O\u2019Connor","year":"2003","unstructured":"O\u2019Connor R. (2003) Regulation of IGF-I receptor signaling in tumor cells. Horm. Metab. Res. 35:771\u20137.","journal-title":"Horm. Metab. Res."},{"key":"1405264_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0305-0491(98)10106-2","volume":"121","author":"AA Butler","year":"1998","unstructured":"Butler AA, Yakar S, Gewolb IH, Karas M, Okubo Y, LeRoith D. (1998) Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121:19\u201326.","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"1405264_CR42","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1038\/sj.onc.1206772","volume":"22","author":"E Surmacz","year":"2003","unstructured":"Surmacz E. (2003) Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene. 22:6589\u201397.","journal-title":"Oncogene"},{"key":"1405264_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jsbmb.2003.09.007","volume":"87","author":"KA Kovacs","year":"2003","unstructured":"Kovacs KA et al. (2003) Differential expression of Akt\/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium. J. Steroid Biochem. Mol. Biol. 87:233\u201340.","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1405264_CR44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jsbmb.2006.08.006","volume":"103","author":"KA Kovacs","year":"2007","unstructured":"Kovacs KA et al.(2007) Phosphorylation of PTEN (phosphatase and tensin homologue deleted on chromosome ten) protein is enhanced in human fibromyomatous uteri. J. Steroid Biochem. Mol. Biol. 103:196\u20139.","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1405264_CR45","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1016\/S0021-9258(18)60952-4","volume":"262","author":"P Zumstein","year":"1987","unstructured":"Zumstein P, Stiles CD. (1987) Molecular cloning of gene sequences that are regulated by insulinlike growth factor I. J. Biol. Chem. 262:11252\u201360.","journal-title":"J. Biol. Chem."},{"key":"1405264_CR46","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/0002-9378(95)91420-X","volume":"172","author":"EY Strawn Jr.","year":"1995","unstructured":"Strawn EY, Jr., Novy MJ, Burry KA, Bethea CL. (1995) Insulin-like growth factor I promotes leiomyoma cell growth in vitro. Am. J. Obstet. Gynecol. 172:1837\u201343; discussion 1843\u20134.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1405264_CR47","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/ncponc0934","volume":"4","author":"Y Tao","year":"2007","unstructured":"Tao Y, Pinzi V, Bourhis J, Deutsch E. (2007) Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway\u2014therapeutic perspectives in cancer. Nat. Clin. Pract. Oncol. 4:591\u2013602.","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"1405264_CR48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nrd2359","volume":"6","author":"DR Clemmons","year":"2007","unstructured":"Clemmons DR. (2007) Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat. Rev. Drug Discov. 6:821\u201333.","journal-title":"Nat. Rev. Drug Discov."}],"updated-by":[{"DOI":"10.2119\/2007-00101.erratum.yu","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2008,9,5]],"date-time":"2008-09-05T00:00:00Z","timestamp":1220572800000}}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/2007-00101.Yu","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/2007-00101.YU.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T15:49:39Z","timestamp":1631288979000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/2007-00101.YU"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,25]]},"references-count":48,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["1405264"],"URL":"https:\/\/doi.org\/10.2119\/2007-00101.yu","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,25]]}}}